This antibody that can binds to human CD19 is useful in the treatment of diseases and disorders, particularly B cell malignancies including acute lymphoblastic leukemia, hairy cell leukemia, chronic lymphocytic leukemia, and non-Hodgkin's lymphoma.
Figure 1 Anti-Human CD19 Antibody scFv Fragment (TAB-1620CL-S(P)) in SPR
SPR assays of TAB-1620CL-S(P).
Antibody capture Chip principle:
Immobilization: Immobilized Anti-Human IgG (Fc) antibody on CM5 chip
Capture: capture the Human CD19,Fc tag
Analyte: the analyte is TAB-1620CL-S(P)
Regeneration: 3M MgCl2
Figure 2 Anti-Human CD19 Antibody scFv Fragment (TAB-1620CL-S(P)) in ELISA
ELISA analysis of TAB-1620CL-S(P) was performed by coating with CD19 Protein, Human, Recombinant (ECD, His Tag).
TAB-1620CL-S(P)-Biotin incubation concentration: 2ng/μL.
The secondary antibody: SA-HRP
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-H17 | Anti-Human CD19 Recombinant Antibody (Denintuzumab Mafodotin) | IF, IP, Neut, FuncS, ELISA, FC, WB | IgG1 - kappa |
TAB-1612CL | Human Anti-CD19 Recombinant Antibody (TAB-1612CL) | Depletion, FuncS | Humanized IgG1 |
TAB-1612CL-S(P) | Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1612CL-S(P)) | Depletion, FuncS | Humanized scFv |
TAB-1625CL-S(P) | Anti-Human CD19 Recombinant Antibody scFv Fragment (396) | Depletion, ELISA | Humanized antibody |
TAB-431CQ | Anti-Human CD19 Recombinant Antibody | ELISA, IHC, FC, IP, IF, FuncS | IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
AGTO-G076E | Anti-CD19 immunotoxin HD37 (IgG)-PE | Cytotoxicity assay, Function study | |
AGTO-G076D | Anti-CD19 immunotoxin HD37 (IgG)-DT | Cytotoxicity assay, Function study | |
AGTO-G076R | Anti-CD19 immunotoxin HD37 (IgG)-RTA | Cytotoxicity assay, Function study | |
AGTO-G076S | Anti-CD19 immunotoxin HD37 (IgG)-Sap | Cytotoxicity assay, Function study | |
AGTO-G076P | Anti-CD19 immunotoxin HD37 (IgG)-PAP | Cytotoxicity assay, Function study |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1611CL | Mouse Anti-CD19 Recombinant Antibody (TAB-1611CL) | Depletion, FuncS | Mouse IgG2a, κ |
TAB-1620CL | Anti-Human CD19 Recombinant Antibody (HD37) | FuncS | |
TAB-1622CL | Mouse Anti-CD19 Recombinant Antibody (TAB-1622CL) | ELISA, FC, Apop, ADCC, FuncS | Mouse IgG |
TAB-1623CL | Mouse Anti-CD19 Recombinant Antibody (TAB-1623CL) | ELISA, FC | Mouse IgG |
TAB-1624CL | Anti-Human CD19 Recombinant Antibody (381) | FC, Inhib, ELISA |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1626CL | Anti-Human CD19 Recombinant Antibody (HB12a) | Depletion | Fully human antibody |
TAB-1627CL | Anti-Human CD19 Recombinant Antibody (HB12b) | Depletion | Fully human antibody |
TAB-1627CL-S(P) | Anti-Human CD19 Recombinant Antibody scFv Fragment (HB12b) | Depletion | Fully human antibody |
TAB-1626CL-F(E) | Anti-Human CD19 Recombinant Antibody Fab Fragment (HB12a) | Depletion | Fully human antibody |
TAB-1627CL-F(E) | Anti-Human CD19 Recombinant Antibody Fab Fragment (HB12b) | Depletion | Fully human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1613CL-S(P) | Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1613CL-S(P)) | Depletion, FuncS | Mouse scFv |
TAB-1614CL-S(P) | Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1614CL-S(P)) | FuncS | Mouse scFv |
TAB-1621CL-S(P) | Anti-Human CD19 Recombinant Antibody scFv Fragment (cHD37) | FuncS | Chimeric antibody (mouse/human) |
TAB-1613CL-F(E) | Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1613CL-F(E)) | Depletion, FuncS | Chimeric (mouse/human) Fab |
TAB-1621CL-F(E) | Anti-Human CD19 Recombinant Antibody Fab Fragment (cHD37) | FuncS | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-061LC | Recombinant Anti-Human CD19 Antibody (Fc glycosylation/Low fucosylated) | ELISA, FC | Chimeric antibody (mouse/human) |
Gly-105LC | Recombinant Anti-Human CD19 Antibody (Fc glycosylation) | ELISA | Mouse antibody |
Gly-141LC | Recombinant Anti-Human CD19 Antibody (Fc glycosylation/Non fucosylated) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-061LC-1 | Recombinant Anti-Human CD19 Antibody (Fc glycosylation/Low fucosylated) | ELISA, FC | Chimeric antibody (mouse/human) |
Gly-141LC-1 | Recombinant Anti-Human CD19 Antibody (Fc glycosylation/Non fucosylated) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0100MZ | Chicken Anti-CD19 Polyclonal IgY | WB | Chicken antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-286CQ | Mouse Anti-CD19 Recombinant Antibody (clone SJ25-C1) | Neut, FC, IHC, IHC-Fr, IP | Mouse IgG1 |
NEUT-287CQ | Mouse Anti-CD19 Recombinant Antibody (clone HIB19) | FC, CyTOF, IHC, Block | Mouse IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-288CQ | Rat Anti-CD19 Recombinant Antibody (clone 1D3) | Depletion, Block, FC | Rat IgG2a |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0538 | Hi-Affi™ Rabbit Anti-CD19 Recombinant Antibody (clone DS538AB) | IHC-P | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0264-CN | Human Anti-CD19 Recombinant Antibody (HPAB-0264-CN) | ELISA, FC | Humanized IgG1, κ |
HPAB-0265-CN | Human Anti-CD19 Recombinant Antibody (HPAB-0265-CN) | ELISA, FC | Humanized IgG1, κ |
HPAB-0266-CN | Human Anti-CD19 Recombinant Antibody (HPAB-0266-CN) | ELISA, FC | Humanized IgG |
HPAB-0267-CN | Human Anti-CD19 Recombinant Antibody (HPAB-0267-CN) | ELISA, FC | Humanized IgG |
HPAB-0268-CN | Human Anti-CD19 Recombinant Antibody (HPAB-0268-CN) | ELISA, FC | Human IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0418LY-F(E) | Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0418LY-F(E)) | ELISA, WB, FC, RIA | Human Fab |
HPAB-0419LY-F(E) | Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0419LY-F(E)) | ELISA, WB, FC, RIA | Human Fab |
HPAB-0420LY-F(E) | Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0420LY-F(E)) | ELISA, WB, FC, RIA | Human Fab |
HPAB-0421LY-F(E) | Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0421LY-F(E)) | ELISA, WB, FC, RIA | Human Fab |
HPAB-0422LY-F(E) | Human Anti-CD19 Recombinant Antibody; Fab Fragment (HPAB-0422LY-F(E)) | ELISA, WB, FC, RIA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-174 | Afuco™ Anti-CD19 ADCC Recombinant Antibody (Taplitumomab), ADCC Enhanced | ELISA, IP, FC, FuncS, Neut, IF | ADCC enhanced antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-2977LY-S(P) | Human Anti-CD19 Recombinant Antibody (clone 1F1); scfv Fragment | ELISA, FC | Human scfv |
HPAB-2978LY-S(P) | Human Anti-CD19 Recombinant Antibody (clone 1H11); scfv Fragment | ELISA, FC | Human scfv |
HPAB-0986WJ-S(P) | Human Anti-CD19 Recombinant Antibody; scFv Fragment (HPAB-0986WJ-S(P)) | ELISA, FC | Human scFv |
HPAB-0987WJ-S(P) | Human Anti-CD19 Recombinant Antibody; scFv Fragment (HPAB-0987WJ-S(P)) | ELISA, FC | Human scFv |
HPAB-0988WJ-S(P) | Human Anti-CD19 Recombinant Antibody; scFv Fragment (HPAB-0988WJ-S(P)) | ELISA, FC | Human scFv |
There are currently no Customer reviews or questions for TAB-1620CL-S(P). Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.